Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Insulin resistance linked to obesity may increase COVID-19 severity.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Many recovered COVID-19 patients in Saudi Arabia still experience symptoms like fatigue and anxiety, especially older adults and those with other health issues.

Genetic differences affect COVID-19 severity and treatment development.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Long COVID patients have more health issues than non-infected people.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Eclipta alba extract may help treat obesity by blocking fat cell formation and lowering blood lipid levels.

Testosterone may both worsen and protect against COVID-19 effects in men.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Hispanics in Northern Nevada had more COVID-19 cases but lower mortality than non-Hispanics.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

Hispanic individuals in Northern Nevada were more affected by COVID-19 but had lower mortality rates than non-Hispanics.

More people are searching for hair transplants online, preferring Follicular Unit Excision over Follicular Unit Transplant. There's also a rise in female patients and interest in beard, eyebrow transplants, and non-surgical treatments like platelet rich plasma.